-
Loading metrics
Eight versus twelve weeks of sofosbuvir-velpatasvir in treatment-naïve non-cirrhotic patients with chronic hepatitis C virus infection: Study protocol for a multicentric, open labelled, randomized, non-inferiority trial (RESOLVE trial)
- Ashish Awasthi,
- Harshita Katiyar,
- Sumit Rungta,
- Amar Deep,
- Vinod Kumar,
- Shalimar,
- Ajay Kumar,
- Prachi Tiwari,
- Amit Goel
x
- Published: May 18, 2023
- https://doi.org/10.1371/journal.pone.0285725